Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-25 @ 3:37 AM
NCT ID:
NCT03420105
Eligibility Criteria:
Inclusion Criteria:
* Major patients under the age of 70;
* Patients who have been treated by surgery or radiotherapy for non-metastatic breast cancer
* Radiotherapy completed for about 6 months
* Level of study 3 "end of primary studies" minimum (Barbizet scale);
* French mother tongue;
* Menopausal women for at least 1 year before the selection visit
* Absence of primary cancer of the central nervous system or brain metastases;
* Absence of previous neurological damage;
* Absence of personality disorders and progressive psychiatric pathology;
* Having signed the informed consent to participate in the study.
Exclusion Criteria:
* Primary cancer other than breast
* Metastatic cancer
* Treated by chemotherapy
* Cognitive function disorders pre-existing to cancer diagnosis
* Patients with paraneoplastic syndrome;
* Evolutionary psychiatric pathology;
* Refusal of participation;
* Patients unable to respond to cognitive tests;
* Drug use or excessive consumption of alcohol.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03420105
Study Brief:
Protocol Section:
NCT03420105